| Title : Serum soluble CD26\/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody - Kaneko_2021_Biomark.Res_9_21 |
| Author(s) : Kaneko Y , Hatano R , Hirota N , Isambert N , Trillet-Lenoir V , You B , Alexandre J , Zalcman G , Valleix F , Podoll T , Umezawa Y , Takao S , Iwata S , Hosono O , Taguchi T , Yamada T , Dang NH , Ohnuma K , Angevin E , Morimoto C |
| Ref : Biomark Res , 9 :21 , 2021 |
| Abstract : |
| PubMedSearch : Kaneko_2021_Biomark.Res_9_21 |
| PubMedID: 33757558 |
| Title : Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates - Camps_2010_Chem.Biol.Interact_187_411 |
| Author(s) : Camps P , Formosa X , Galdeano C , Gomez T , Munoz-Torrero D , Ramirez L , Viayna E , Gomez E , Isambert N , Lavilla R , Badia A , Clos MV , Bartolini M , Mancini F , Andrisano V , Bidon-Chanal A , Huertas O , Dafni T , Luque FJ |
| Ref : Chemico-Biological Interactions , 187 :411 , 2010 |
| Abstract : |
| PubMedSearch : Camps_2010_Chem.Biol.Interact_187_411 |
| PubMedID: 20167211 |
| Title : Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds - Camps_2009_J.Med.Chem_52_5365 |
| Author(s) : Camps P , Formosa X , Galdeano C , Munoz-Torrero D , Ramirez L , Gomez E , Isambert N , Lavilla R , Badia A , Clos MV , Bartolini M , Mancini F , Andrisano V , Arce MP , Rodriguez-Franco MI , Huertas O , Dafni T , Luque FJ |
| Ref : Journal of Medicinal Chemistry , 52 :5365 , 2009 |
| Abstract : |
| PubMedSearch : Camps_2009_J.Med.Chem_52_5365 |
| PubMedID: 19663388 |